Global Insulin Pump Market, Users, Forecast, Reimbursement Policy 2010-2024 - Research and Markets

DUBLIN--()--The "Global Insulin Pump Market, Users, Forecast, Reimbursement Policy (Countries: US, Canada, Germany, Australia, France, Netherlands, Switzerland, Sweden, Israel, UK & Japan) Clinical Trials, Training Model, Companies Analysis" report has been added to Research and Markets' offering.

Globally, insulin pump market is anticipated to cross US$ 8 Billion by 2024

The growth of diabetes management policy and expansion of diabetes knowledge over the world, the market for insulin pump will develop positive outlook in future year. With the assistance of insulin pump patients deal with their diabetes with a high level of proficiency without visiting their doctor.

Global insulin pump market is growing due to different growth drivers such as ageing population, rise in diabetic population and evolution of new products. Though, the market faces certain hurdles like a threat from the implantable insulin pump, the high cost of insulin pumps, complicated software used in insulin pumps and invention of artificial pancreas etc.

US controls more than 50% of the Global Insulin Pump Market

In the United States, Insulin Pump has now become a favored and renowned device for Type1 diabetes patients. The spontaneity of using insulin pump is gaining inclusive appreciation in the market as insulin delivery systems. The better execution of public & private reimbursement policy about the insulin pump makes the United States world's largest insulin pump market.

Germany records the highest number of insulin pump user due to its overall population and relatively number of type 1 diabetes patients in Europe.

Key Topics Covered:

  1. Executive Summary
  2. Global-Insulin Pump Users & Forecast
  3. Global-Insulin Pump Market & Forecast
  4. Global-Insulin Pump Market Share & Forecast
  5. Training Model for Patients & HCP-of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
  6. Differentiation Points of Insulin Pump Products Available Worldwide
  7. United States-Diabetes Population (2010-2024)
  8. United States-Insulin Analysis (2010-2024)
  9. Canada-Diabetes Analysis (2010-2024)
  10. Canada Insulin Pump Analysis (2010-2024)
  11. Germany-Diabetes Analysis (2010-2024)
  12. Germany Insulin Pump Analysis (2010-2024)
  13. Australia-Diabetes Analysis (2010-2024)
  14. Australia Insulin Pump Analysis (2010-2024)
  15. France-Diabetes Analysis (2010-2024)
  16. France Insulin Pump Analysis (2010-2024)
  17. Netherlands-Diabetes Analysis (2010-2024)
  18. Netherlands Insulin Pump Analysis (2010-2024)
  19. Switzerland-Diabetes Analysis (2010-2024)
  20. Switzerland Insulin Pump Analysis (2010-2024)
  21. Sweden-Diabetes Analysis (2010-2024)
  22. Sweden Insulin Pump Analysis (2010-2024)
  23. Israel-Diabetes Analysis (2010-2024)
  24. Israel Insulin Pump Analysis (2010-2024)
  25. United Kingdom-Diabetes Analysis (2010-2024)
  26. United Kingdom Insulin Pump Analysis (2010-2024)
  27. Japan-Diabetes Analysis (2010-2024)
  28. Japan Insulin Pump Analysis (2010-2024)
  29. Key Companies Analysis
  30. Companies - Insulin Pump Clinical Trials
  31. Growth Drivers
  32. Challenges

Companies Mentioned

  • Medtronic
  • Insulet Corporation
  • Tandem Diabetes Care
  • Roche
  • Animas Corporation

For more information about this report visit https://www.researchandmarkets.com/research/72h72z/global_insulin

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diabetes Devices, Infusions and Injectables

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diabetes Devices, Infusions and Injectables